Ali J. Satvat Bridge Bio Pharma, Inc. (BBIO) insider trading activity

BBIO Quotes by TradingView

Ali J. Satvat is of BridgeBio Pharma, Inc.. Currently has a direct ownership of 165,993 shares of BBIO, which is worth approximately $7.92 Million. The most recent transaction as insider was on Jun 20, 2025, when has been sold 6,589 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 166K
4.13% 3M change
n/a 12M change
Total Value Held $7.92 Million

Ali J. Satvat Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 20 2025
BUY
Grant, award, or other acquisition
-
6,589 Added 3.82%
165,993 Common Stock
Dec 30 2024
BUY
Exercise of conversion of derivative security
$2,862,895 $17.96 p/Share
159,404 Added 50.0%
159,404 Common Stock

Also insider at

EIDX
Eidos Therapeutics, Inc.
Director
CHRS
Coherus BioSciences, Inc. Healthcare
AJS

Ali J. Satvat

Menlo Park, CA

Track Institutional and Insider Activities on BBIO

Follow BridgeBio Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

News

Receive news related to BridgeBio Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BBIO